Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure forHelicobacter pyloriinfection
Author(s) -
Ji Hyun Lim
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i46.13124
Subject(s) - medicine , helicobacter pylori , moxifloxacin , urea breath test , gastroenterology , amoxicillin , breath test , adverse effect , rabeprazole , combination therapy , surgery , antibiotics , helicobacter pylori infection , microbiology and biotechnology , biology
To assess the efficacy of moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori (H. pylori) eradication.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom